GSK reaches deal to end patent dispute
14th Nov 2006, 18:42 GMT
GlaxoSmithKline has agreed to a deal in a patent dispute that will allow a California company to produce a generic version of a GSK drug.
GSK reaches deal to end patent dispute related news:
- Spectrum settles patent dispute with GSK — Pharmaceutical Business Review Latest News
- Spectrum Says It Reaches Glaxo Settlement — Pharmaceuticals News from StratCenter.com
- United Therapeutics subsidiary settles patent dispute — bizjournals.com Health Care:Biotechnology headlines
- Par Pharmaceutical Announces Agreement With GlaxoSmithKline to Settle Imitrex Injection Patent Litigation — Partnerships/ Joint Ventures News from StratCenter.com
- Microsoft, Seiko Epson expand patent license deal — ActiveWin.com Headlines
- SpectraScience files new patent application — News-Medical News Feed
- Ex-Fannie Mae Chief Ends Pay Dispute — NYT > Business
- ProactiveNet Granted U.S. Patent for Correlation and Root Cause of Performance Events and Abnormalities — ArriveNet : Technology
- Officer agrees to plea deal — azcentral.com | mesa
- Officer agrees to plea deal in domestic case — azcentral.com | mesa
Latest news from Latest news from Triangle Business Journal:
- Eisai breaks ground on $90M Durham expansion
- Icagen losses mount in 3Q
- Xerium stock plunges after earnings report
- Golden Leaf chips in $223,000 for Sanford dental program
- UNC names Butch Davis head football coach
- Despite hikes, N.C. teacher pay still below average
- Clearwire to make Triangle debut, hire 50 employees
- Trimeris swaps CEOs, says it will slash jobs
- SunTrust announces CEO change
- UNC pushes endowment to $1.48B on 19.2% investment return